From: Prognostic biomarker SMARCC1 and its association with immune infiltrates in hepatocellular carcinoma
immune cells | None | Purity | tumor cells | None | Purity | ||||
---|---|---|---|---|---|---|---|---|---|
Rho | P | Rho | P | Rho | P | Rho | P | ||
PD1 | 0.23 | < .001 | 0.23 | < .001 | PDL1 | 0.28 | < .001 | 0.29 | < .001 |
CTLA4 | 0.20 | < .001 | 0.22 | < .001 | PDL2 | 0.10 | 0.051 | 0.11 | 0.031 |
CD28 | 0.30 | < .001 | 0.31 | < .001 | CD80 | 0.20 | < .001 | 0.20 | < .001 |
LAG3 | 0.12 | 0.014 | 0.14 | 0.007 | CD86 | 0.28 | < .001 | 0.29 | < .001 |
CD226 | 0.24 | < .001 | 0.25 | < .001 | FGL1 | − 0.23 | < .001 | − 0.21 | < .001 |
TIGIT | 0.21 | < .001 | 0.24 | < .001 | LGALS3 | 0.19 |  < .001 | 0.20 | < .001 |
CD96 | 0.18 | < .001 | 0.20 | < .001 | CD112 | 0.24 | < .001 | 0.24 | < .001 |
BTLA | 0.18 | < .001 | 0.19 | < .001 | CD115 | 0.20 | < .001 | 0.22 | < .001 |
VISTA | 0.27 | < .001 | 0.27 | < .001 | HVEM | 0.16 | 0.001 | 0.16 | 0.002 |
TIM3 | 0.27 | < .001 | 0.29 | < .001 | CEACAM1 | 0.11 | 0.025 | 0.13 | 0.009 |